SCHEMBL6635535

SCHEMBL6635535

CC(=O)N1Cc2cc(-c3ccccc3CN(C)C)ccc2NCC1Cc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FNTA P49354 4/20 0.39
FNTB P49356 4/20 0.39
ABCB1 P08183 3/20 0.37
HSD17B3 P37058 2/20 0.37
METAP2 P50579 1/20 0.36
GRM2 Q14416 1/20 0.36
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
ITGB1 P05556 1/20 0.35
ITGA4 P13612 1/20 0.35
ITGB7 P26010 1/20 0.35
DAGLB Q8NCG7 1/20 0.35
DAGLA Q9Y4D2 1/20 0.35
CYP3A4 P08684 3/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
SLC6A3 Q01959 1/20 0.34
MLNR O43193 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6615989 1.00 FNTA (0.39) FNTAFNTBABCB1HSD17B3METAP2
SCHEMBL6634139 0.84 FNTA (0.45) FNTAFNTBABCB1HSD17B3
SCHEMBL6633403 0.84 FNTA (0.45) FNTAFNTBABCB1HSD17B3
SCHEMBL6617952 0.81 FNTA (0.46) FNTAFNTBABCB1HSD17B3DAGLB
SCHEMBL6632636 0.78 FNTA (0.56) FNTAFNTBABCB1HSD17B3
SCHEMBL3501311 0.77 FNTA (0.50) FNTAFNTBGRM2
SCHEMBL3501316 0.77 FNTA (0.50) FNTAFNTBGRM2
SCHEMBL7687860 0.77 MEN1 (0.55) METAP2GRM2SLC6A2SLC6A4CYP3A4
SCHEMBL6618481 0.77 MEN1 (0.55) METAP2GRM2SLC6A2SLC6A4CYP3A4
SCHEMBL6630439 0.72 FNTA (0.44) FNTAFNTBABCB1HSD17B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1481975-A1 Inhibitors of farnesyl protein transferase BRISTOL-MYERS SQUIBB COMPANY (US) 2004-12-01 EP disclosed
US-6455523-B1 ADMINISTERING 1,4-BENZODIAZEPINE DERIVATIVE AS ANTITUMOR OR ANTICARCINOGENIC AGENT BRISTOL-MYERS SQUIBB COMPANY 2002-09-24 US disclosed
US-6011029-A BENZODIAZEPINE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2000-01-04 US disclosed